Recent Finacing
Recent Raise
Avacta is a clinical-stage biopharmaceutical company developing precision oncology drug conjugates, including faridoxorubicin, built on its pre|CISION platform.
Focus Areas
Total Raised
Funding round
See the team members at Avacta.
